Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer

Name: Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer
Published: 2018
License: Public Domain

Stanford University · 2018

ClinicalTrials.gov · Datasets · License: Public Domain · 2018

Open Source ↗

kras gene mutation, metastatic malignant neoplasm in the brain, recurrent non-small cell lung carcinoma, stage iv non-small cell lung cancer ajcc v7, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer

Related documents